EP2333110
IN VITRO METHOD FOR PROGNOSIS OR PREDICTION OF RESPONSE BY PATIENTS WITH RHEUMATOID ARTHRITIS TO TREATMENT WITH TNF-alpha FACTOR BLOCKING AGENTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.9.2009EP published:
19.11.2014EP application number:
09815707.6
EPO information:
European Patent Register
Max expiry date:
17.9.2029
Title:
IN VITRO METHOD FOR PROGNOSIS OR PREDICTION OF RESPONSE BY PATIENTS WITH RHEUMATOID ARTHRITIS TO TREATMENT WITH TNF-alpha FACTOR BLOCKING AGENTS
Timeline
Today
18.9.2009EP application
19.11.2014EP Publication
Owner
Name:
Fundacio Institut de Recerca de l'Hospital Universitari Vall d'HebronAddress:
Passeig Vall d'Hebron, 119-129, 08035, Barcelona, ES
Inventor
Name:
JULIÁ CANO, AntonioAddress:
Barcelona, ES
Name:
MARSAL BARRIL, SaraAddress:
Barcelona, ES
Priority
Number:
200802713Date:
24.9.2008Country:
ES
Classification
Categories:
C12Q 1/68